Business Context and Reporting Period
This Form 8-K filing by Universal Health Services, Inc. (UHS) reports on events occurring on March 26, 2026. The filing details the approval of executive compensation arrangements, including annual incentive bonus performance goals for the fiscal year ending December 31, 2026, and the granting of long-term stock-based awards.
Key Financial Metrics and Compensation Details
The filing does not report consolidated revenue, profit, cash flow, or debt metrics for the company. Instead, it focuses on executive compensation metrics:
- Discretionary Bonus: A cash bonus of $1.07 million was approved for Executive Chairman Alan B. Miller for the year ended December 31, 2025.
- Stock Price: Awards were calculated based on a Class B Common Stock closing price of $185.09 per share on March 26, 2026.
- Performance Metrics:
- Short-Term: Adjusted net income per diluted share and return on capital.
- Long-Term: Three-year average Adjusted EBITDA net of Non-Controlling Interest (NCI).
Material Changes and New Compensation Structures
The Compensation Committee implemented several changes to the executive incentive structure effective March 26, 2026:
- Long-Term Incentive Measurement: Performance-Based Restricted Stock Units (PBRSUs) will now be based on the average performance over a three-year measurement period (2026-2028), rather than aggregate performance at the end of the third year.
- Payout Thresholds:
- Minimum Threshold: 90% of target Adjusted EBITDA results in a 50% payout (unchanged).
- Maximum Threshold: 110% or greater of target Adjusted EBITDA now results in a 200% payout, increased from the previous 150%.
- Cliff: No payout is provided for performance below the 90% minimum threshold.
- Divisional Targets: For EVPs Edward H. Sim and Matthew J. Peterson, 75% of their bonus is tied to divisional income targets (acute care and behavioral health), adjusted for estimated cost of capital.
2026 Executive Stock Awards (RSUs and PBRSUs)
| Name | Title | RSUs Granted | PBRSUs Granted (at Target) |
|---|---|---|---|
| Marc D. Miller | CEO and President | 29,715 | 29,715 |
| Alan B. Miller | Executive Chairman | 14,153 | 14,153 |
| Steve G. Filton | EVP and CFO | 6,850 | 6,850 |
| Edward H. Sim | EVP and President-Acute Care | 6,404 | 6,404 |
| Matthew J. Peterson | EVP and President-Behavioral Health | 5,627 | 5,627 |
Outlook, Risks, and Management Commentary
The filing indicates a strategic shift to align executive compensation more closely with peer group practices by increasing the upside potential for long-term performance (200% payout at maximum threshold). The company emphasizes the use of "Adjusted" metrics (Adjusted Net Income and Adjusted EBITDA) which exclude nonrecurring or non-operational items, such as changes in non-marketable securities and specific tax impacts related to ASU 2016-09.
Key Facts for Investor Verification
- Verify the specific Adjusted EBITDA targets for the 2026-2028 period in the company's Proxy Statement to assess the difficulty of achieving the new 200% payout threshold.
- Confirm the vesting schedule for the 2026 RSUs (four equal annual installments) and the specific performance conditions for the PBRSUs.
- Review the employment agreement for Marc D. Miller to confirm the stipulated 150% target bonus percentage.
- Monitor future filings for the actual divisional income results for the Acute Care and Behavioral Health segments, which drive 75% of the bonuses for two senior executives.